Voyager Therapeutics (VYGR) Net Margin Growth (1y) (2016 - 2026)
Voyager Therapeutics (VYGR) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -59,816.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59,816.00 |
| Dec 31, 2025 | 36,893.00 |
| Sep 30, 2025 | -17,197.00 |
| Jun 30, 2025 | -60,768.00 |
| Mar 31, 2025 | -42,113.00 |
| Dec 31, 2024 | -60,991.00 |
| Sep 30, 2024 | 52,464.00 |
| Jun 30, 2024 | 41,894.00 |
| Mar 31, 2024 | -14,053.00 |
| Dec 31, 2023 | -146,167.00 |
| Sep 30, 2023 | -60,425.00 |
| Jun 30, 2023 | 222,753.00 |
| Mar 31, 2023 | 332,240.00 |
| Dec 31, 2022 | 150,392.00 |
| Sep 30, 2022 | 173,905.00 |
| Jun 30, 2022 | 46,692.00 |
| Mar 31, 2022 | -189,616.00 |
| Dec 31, 2021 | 26,396.00 |
| Sep 30, 2021 | -176,880.00 |
| Jun 30, 2021 | -307,968.00 |